Although no significant differences in SKP2 protein levels were found between cancer tissues and control tissues for the other nine neoplasms (e.g., BLCA), the expression of SKP2 at both protein and mRNA levels exhibited the same trends for most of these neoplasms (Supplementary Material 4). Here, SKP2 is linked to bladder transitional cell carcinoma.